Bayer Schering Pharma has joined the ranks of firms switching to restrictive distribution arrangements in the UK.
The pharma company, which is the prescription medicines arm of Bayer HealthCare, is following a trend set by GlaxoSmithKline, Pfizer, AstraZeneca and Novartis.
Around 30 of Bayer Schering Pharma's drugs are affected, including erectile dysfunction brand Levitra, antibiotic Ciproxin and blood pressure treatment Adalat.
From July, these and other products will be sold only through wholesalers AAH Pharmaceuticals, Alliance Healthcare (Distribution) - formerly UniChem - and Phoenix Healthcare Distribution.
More
No comments:
Post a Comment